| |
 |
Monoclonal Antibody-Based Targeted Therapy in Breast Cancer
|
| |
|
pp.99-106 (8) Authors: Kadri Altundag, Francisco J. Esteva, Banu Arun |
| |
|
|
| |
|
Development of Prodrugs for Enzyme-Mediated, Tumor-Selective Therapy
|
| |
|
pp.107-113 (7) Authors: K. Jin Yoon, Philip M. Potter, Mary K. Danks |
| |
|
|
| |
|
Anti-Angiogenic Therapy as a Cancer Treatment Paradigm
|
| |
|
pp.115-130 (16) Authors: Mohanraj Dhanabal, Mike Jeffers, William J. LaRochelle |
| |
|
|
| |
|
Activation of p53 by Specific Agents in Potential Cancer Therapy
|
| |
|
pp.131-135 (5) Authors: John W. Ho, Jing Zheng Song, Yuet Kin Leung |
| |
|
|
| |
|
Metal Complexes with Aromatic N-Containing Ligands as Potential Agents in Cancer Treatment
|
| |
|
pp.137-147 (11) Authors: Guanghua Zhao, Huakuan Lin |
| |
|
|
| |
|
Medicinal Properties of Neem Leaves: A Review
|
| |
|
pp.149-156 (8) Authors: R. Subapriya, S. Nagini |
| |
|
|
| |
|
Specific Targets in Tumor Tissue for the Delivery of Therapeutic Genes
|
| |
|
pp.157-171 (15) Authors: Michael Gunther, Ernst Wagner, Manfred Ogris |
| |
|
|
| |
|
Cytotoxic and Antitumor Potentialities of Aporphinoid Alkaloids
|
| |
|
pp.173-182 (10) Authors: C. Stevigny, C. Bailly, J. Quetin-Leclercq |
| |
|
|
